Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

10.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.0K
Mismatch Repair01:36

Mismatch Repair

44.8K
Overview
44.8K
Mismatch Repair01:20

Mismatch Repair

6.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.9K
Mismatch Repair01:36

Mismatch Repair

12.2K
12.2K
Proofreading01:43

Proofreading

19.4K
19.4K
Proofreading01:43

Proofreading

61.9K
Overview
61.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Does treatment of jaundice matter before pancreaticoduodenectomy?: Results from an international multicentre Recurrence After Whipple (RAW) study.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2026
Same journal

The Application of Platysma Myocutaneous Flap in Tracheostomy after Total Laryngectomy: A Novel Surgical Technique.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2026
Same journal

New Perfusion and Preservation Strategies for Donor Hearts.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2026
Same journal

Use of Human Amnion/Chorion Membrane as a Protective Barrier in Complicated Diverticulitis Patients Undergoing Colorectal Resections.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2026
Same journal

Erratum.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2026
Same journal

Erratum.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2026
See all related articles

Related Experiment Video

Updated: Mar 20, 2026

Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy
03:25

Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy

Published on: June 16, 2022

1.5K

Erratum

    European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes
    |March 18, 2026
    PubMed
    Summary
    This summary is machine-generated.

    This study addresses desensitization strategies for heart transplant recipients with pre-existing antibodies. It highlights updated information on open access licensing for relevant research.

    More Related Videos

    Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
    09:41

    Reconstitution Of β-catenin Degradation In Xenopus Egg Extract

    Published on: June 17, 2014

    12.5K
    Surgical Correction for Pediatric Epiblepharon and Trichiasis
    03:59

    Surgical Correction for Pediatric Epiblepharon and Trichiasis

    Published on: July 8, 2025

    741

    Related Experiment Videos

    Last Updated: Mar 20, 2026

    Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy
    03:25

    Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy

    Published on: June 16, 2022

    1.5K
    Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
    09:41

    Reconstitution Of β-catenin Degradation In Xenopus Egg Extract

    Published on: June 17, 2014

    12.5K
    Surgical Correction for Pediatric Epiblepharon and Trichiasis
    03:59

    Surgical Correction for Pediatric Epiblepharon and Trichiasis

    Published on: July 8, 2025

    741

    Area of Science:

    • Immunology
    • Cardiology
    • Transplantation

    Background:

    • Heart transplantation is a life-saving procedure for end-stage heart failure.
    • Immunized recipients, those with pre-existing antibodies, face significant challenges due to antibody-mediated rejection.
    • Effective desensitization protocols are crucial to improve outcomes in these high-risk patients.

    Purpose of the Study:

    • To review and discuss current desensitization strategies for immunized heart transplant recipients.
    • To provide an updated overview of managing antibody-mediated rejection in this population.
    • To inform clinicians on optimizing immunosuppression and desensitization protocols.

    Main Methods:

    • Review of existing literature on desensitization protocols in heart transplantation.
    • Analysis of clinical data and outcomes related to various desensitization approaches.
    • Discussion of emerging strategies and future directions in managing immunized recipients.

    Main Results:

    • Desensitization strategies aim to reduce the level of pre-formed antibodies before transplantation.
    • Various protocols involving plasmapheresis, intravenous immunoglobulin, and rituximab have shown variable success.
    • Careful patient selection and post-transplant monitoring are critical for successful outcomes.

    Conclusions:

    • Desensitization is a viable strategy to enable transplantation in selected immunized patients.
    • Tailored protocols and vigilant management are essential to mitigate rejection risks.
    • Continued research is needed to refine desensitization techniques and improve long-term graft survival.